Search | IOVS | ARVO Journals

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Quantitative analysis of real-world reduction in intraretinal and subretinal fluid compartments following switch of anti-VEGF agent to faricimab in the treatment of neovascular age-related macular degeneration

Giacomo Boscia; Charles Patrick O'Neill; Gihan Samarasinghe; Sophiana Maya Michele Lindenberg; Anna Urrea; Giulia Corradetti; Stephanie Mauger; SriniVas R Sadda; Devinder Chauhan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2119.

ARVO Annual Meeting Abstract June 2024

Association between visual outcomes and macular fluid subtypes at initiation of anti-VEGF treatment for neovascular age-related macular degeneration - a real-world study

Kathryn Stucker; Giang Do; Charles Patrick O'Neill; Stephanie Mauger; Gihan Samarasinghe; Anna Urrea; Giulia Corradetti; Devinder Chauhan; Sophiana Maya Michele Lindenberg; Ayesha Nuri Karamat; Muneeswar Gupta Nittala; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4358.

ARVO Annual Meeting Abstract June 2024

Accuracy of Automated Subretinal Fluid Volume Quantification Using the Macuject Algorithm

Swetha Bindu Velaga; Muneeswar Gupta Nittala; Gihan Samarasinghe; Devinder Chauhan; Charles Clifton Wykoff; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2276.

ARVO Annual Meeting Abstract June 2024

Early real-world fluid-free treatment interval extension following switch to faricimab in the treatment of neovascular age-related macular degeneration with a treat and extend regimen - the first 9 months

Anna Urrea; Charles Patrick O'Neill; Gihan Samarasinghe; Stephanie Mauger; Giang Do; Sophiana Maya Michele Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4384.

ARVO Annual Meeting Abstract June 2024

Quantifying macular fluid fluctuation in anti-VEGF treated neovascular AMD and its impact on visual acuity - a real world study

Kara Jones; Charles Patrick O'Neill; Giang Do; Stephanie Mauger; Anna Urrea; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6489.

ARVO Annual Meeting Abstract June 2024

Real-World Prevalence and Progress of Intraretinal and Subretinal Fluid in Eyes Switched to Faricimab for the treatment of Neovascular Age-Related Macular Degeneration

Ayesha Nuri Karamat; Stephanie Mauger; Charles Patrick O'Neill; Anna Urrea; Giulia Corradetti; Devinder Chauhan; Gihan Samarasinghe; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3827.

ARVO Annual Meeting Abstract June 2023

Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)

Ayesha Nuri Karamat; Charles O'Neill*; Giulia Corradetti; Sophiana Lindenberg; Jasaman Tojjar; Louay Almidani; Giang Do; Stephanie Mauger; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3726.

ARVO Annual Meeting Abstract June 2023

Factors associated with switching intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in the treatment of neovascular age-related macular degeneration (nAMD)

Stephanie Mauger; Charles O'Neill*; Giang Do; Sophiana Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2194.

ARVO Annual Meeting Abstract June 2023

Visual and treatment interval outcomes after switching anti-VEGF therapy in the treatment of nAMD

Sophiana Lindenberg; Charles O'Neill*; Giulia Corradetti; Giang Do; Stephanie Mauger; Ayesha Nuri Karamat; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2183.

ARVO Annual Meeting Abstract June 2023

Clinical relevance of the time course of visual improvement following real-world anti-vascular endothelial growth factor (Anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD)

Charles Patrick O'Neill; Giang Do; Sophiana Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2184.

ARVO Annual Meeting Abstract July 2018

Pitfalls of Ganglion Cell Complex Analysis in Eyes With Vitreomacular Traction Syndrome

Hugh Slifirski; Mathew Rawlings; Queena Qin; Devinder Singh Chauhan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2112.

ARVO Annual Meeting Abstract June 2013

Early fluid clearance following intravitreal ranibizumab injection for neovascular age-related macular degeneration

Kathy Jao; Devinder Chauhan

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6272.

Retina June 2011

Variants in the APOE Gene Are Associated with Improved Outcome after Anti-VEGF Treatment for Neovascular AMD

PDF

Sanjeewa S. Wickremasinghe; Jing Xie; Jonathan Lim; Devinder S. Chauhan; Luba Robman; Andrea J. Richardson; Gregory Hageman; Paul N. Baird; Robyn Guymer
TAGS: anti-vascular endothelial growth factor therapy, apolipoprotein e, exudative age-related macular degeneration, genes, treatment outcome, alleles
Invest. Ophthalmol. Vis. Sci.. 2011; 52(7):4072-4079. https://doi.org/10.1167/iovs.10-6550

ARVO Annual Meeting Abstract April 2011

Retinal Functional Improvement With Nano-laser Treatment In High Risk Early Age-related Macular Degeneration

Robyn H. Guymer; Kate Brassington; Peter N. Dimitrov; Mary Varsamidis; Galina Makeyeva; Khin Zaw Aung; Devinder Chauhan; Algis Vingrys; Chi Luu

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1670.

Retina September 1999

The Interpretation of Optical Coherence Tomography Images of the Retina

PDF

Devinder Singh Chauhan; John Marshall
TAGS: body tissue, optical coherence tomography, retina, ablation, lasers
Invest. Ophthalmol. Vis. Sci.. 1999; 40(10):2332-2342.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Quantitative analysis of real-world reduction in intraretinal and subretinal fluid compartments following switch of anti-VEGF agent to faricimab in the treatment of neovascular age-related macular degeneration

Association between visual outcomes and macular fluid subtypes at initiation of anti-VEGF treatment for neovascular age-related macular degeneration - a real-world study

Accuracy of Automated Subretinal Fluid Volume Quantification Using the Macuject Algorithm

Early real-world fluid-free treatment interval extension following switch to faricimab in the treatment of neovascular age-related macular degeneration with a treat and extend regimen - the first 9 months

Quantifying macular fluid fluctuation in anti-VEGF treated neovascular AMD and its impact on visual acuity - a real world study

Real-World Prevalence and Progress of Intraretinal and Subretinal Fluid in Eyes Switched to Faricimab for the treatment of Neovascular Age-Related Macular Degeneration

Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)

Factors associated with switching intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in the treatment of neovascular age-related macular degeneration (nAMD)

Visual and treatment interval outcomes after switching anti-VEGF therapy in the treatment of nAMD

Clinical relevance of the time course of visual improvement following real-world anti-vascular endothelial growth factor (Anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD)

Pitfalls of Ganglion Cell Complex Analysis in Eyes With Vitreomacular Traction Syndrome

Early fluid clearance following intravitreal ranibizumab injection for neovascular age-related macular degeneration

Variants in the APOE Gene Are Associated with Improved Outcome after Anti-VEGF Treatment for Neovascular AMD

Retinal Functional Improvement With Nano-laser Treatment In High Risk Early Age-related Macular Degeneration

The Interpretation of Optical Coherence Tomography Images of the Retina

To View More...

You must be signed into an individual account to use this feature.